EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of Magnetic Particle–Based Chemiluminescence Immunoassays for Detecting PCV2 VLP‐ and Rep‐Specific Antibodies and Their Combined Use for Immune Evaluation and Replication‐Associated Exposure Assessment

Mingxi Gou iD, Xiaoqing Song iD, Jie Fan iD, Zhixiong Chen iD, Zihao Kuang iD, Mengyao Lu iD, Zhongxin Fan iD, Meng Ge iD

Transboundary and Emerging Diseases · 2026-01 · 2026 (1)

DOI: 10.1155/tbed/3733817 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transboundary and Emerging Diseases, online erschienen am 31.05.2026. Verfasst von Mingxi Gou und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Hunan Agricultural University, Changsha, China, hunau.edu.cn. Hauptthemen laut MEDLINE: Circovirus, Antibodies, Viral, Circoviridae Infections, Swine Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Hunan Province of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Porcine circovirus 2 (PCV2) remains a major swine pathogen, and interpretation of capsid protein (Cap)–based serology is challenging in vaccinated populations because vaccine‐induced Cap antibodies overlap with replication‐associated serological signals. To address this issue, we developed two fully automated magnetic particle–based chemiluminescence immunoassays (CLIAs), including a Cap virus‐like particle (VLP)–based assay (VLPs‐CLIA) for evaluating Cap antibody response intensity and a replication‐associated protein (Rep)–based assay (rRep‐CLIA) for assessing replication‐associated serological exposure or pressure. We produced self‐assembled PCV2 Cap VLPs and recombinant Rep in a prokaryotic system and covalently coupled them to carboxylated magnetic beads for fully automated CLIAs. VLPs‐CLIA was calibrated and reported in activity units (U), whereas rRep‐CLIA was interpreted as a threshold‐based qualitative assay using a relative light unit (RLU) cut‐off. Analytical performance and agreement with reference enzyme‐linked immunosorbent assays (ELISAs) were evaluated using longitudinal and field serum samples. VLPs‐CLIA detected antibodies up to 1:25,600, approximately twofold higher than the reference ELISA (1:12,800), with 95.68% agreement (Kappa = 0.876, p < 0.001). rRep‐CLIA agreed well with Rep‐ELISA (94.86%; Kappa = 0.846, p < 0.001) and provided a complementary signal consistent with replication‐associated exposure. Both assays showed good precision (coefficients of variation [CVs] ranging from 2.83% to 6.94%) and good reagent stability. In field samples, VLPs‐CLIA tracked postvaccination Cap kinetics, whereas Rep seropositivity increased with age and exposure background, suggesting heterogeneous replication–associated pressure among herds. The two assays together support complementary herd‐level interpretation of vaccine‐induced Cap immunity and replication‐associated serological exposure, particularly in Cap‐vaccinated populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CircovirusAntibodies, ViralCircoviridae InfectionsSwine DiseasesLuminescent MeasurementsAnimalsImmunoassaySwineCapsid ProteinsVirus Replication

Stichwörter der Autor:innen

Rep proteinchemiluminescence immunoassay (CLIA)porcine circovirus 2 (PCV2)replication-associated exposureserological surveillancevirus-like particles (VLPs)

Substanzen

Antibodies, ViralCapsid Proteins

Autor:innen und Institutionen

  • College of Veterinary Medicine, Hunan Agricultural University, Changsha, China, hunau.edu.cn.
  • Hunan Engineering Technology Research Center of Veterinary Drugs, Hunan Agricultural University, Changsha, 410128, Hunan, China, hunau.edu.cn.
  • Hunan Animal Disease Prevention and Control Center, Changsha, 410128, Hunan, China.

ORCID-Profile: Mingxi Gou, Xiaoqing Song, Jie Fan, Zhixiong Chen, Zihao Kuang, Mengyao Lu, Zhongxin Fan, Meng Ge

Förderung

  • National Natural Science Foundation of China
  • Key Research and Development Program of Hunan Province of China

Zitieren

APA

Gou, M., Song, X., Fan, J., Chen, Z., Kuang, Z., Lu, M., Fan, Z., & Ge, M. (2026). Development of Magnetic Particle–Based Chemiluminescence Immunoassays for Detecting PCV2 VLP‐ and Rep‐Specific Antibodies and Their Combined Use for Immune Evaluation and Replication‐Associated Exposure Assessment. Transboundary and Emerging Diseases, 2026(1). https://doi.org/10.1155/tbed/3733817

Vancouver

Gou M, Song X, Fan J, Chen Z, Kuang Z, Lu M, et al. Development of Magnetic Particle–Based Chemiluminescence Immunoassays for Detecting PCV2 VLP‐ and Rep‐Specific Antibodies and Their Combined Use for Immune Evaluation and Replication‐Associated Exposure Assessment. Transboundary and Emerging Diseases. 2026;2026(1). doi:10.1155/tbed/3733817

BibTeX
@article{Gou2026,
  author = {Gou, Mingxi and Song, Xiaoqing and Fan, Jie and Chen, Zhixiong and Kuang, Zihao and Lu, Mengyao and Fan, Zhongxin and Ge, Meng},
  title = {Development of Magnetic Particle–Based Chemiluminescence Immunoassays for Detecting PCV2 VLP‐ and Rep‐Specific Antibodies and Their Combined Use for Immune Evaluation and Replication‐Associated Exposure Assessment},
  journal = {Transboundary and Emerging Diseases},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/tbed/3733817}
}
Kostenlos starten →